174 related articles for article (PubMed ID: 20332211)
1. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
[TBL] [Abstract][Full Text] [Related]
2. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors.
Kempná P; Körner M; Waser B; Hofer G; Nuoffer JM; Reubi JC; Flück CE
Mol Cell Endocrinol; 2010 Jan; 314(1):101-9. PubMed ID: 19699258
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
11. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
[TBL] [Abstract][Full Text] [Related]
12. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
Reubi JC; Gugger M; Waser B; Schaer JC
Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
[TBL] [Abstract][Full Text] [Related]
13. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
17. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
19. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis.
Yokosuka M; Dube MG; Kalra PS; Kalra SP
Peptides; 2001 Mar; 22(3):507-14. PubMed ID: 11287108
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.
Ruscica M; Dozio E; Boghossian S; Bovo G; Martos Riaño V; Motta M; Magni P
Endocrinology; 2006 Mar; 147(3):1466-73. PubMed ID: 16339211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
